Camurus Competitors and Similar CompaniesClear all
Camurus's competitors and similar companies include Kamada Pharmaceuticals and Travere Therapeutics.
 Camurus Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions. |  Kamada Pharmaceuticals Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications. |  Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. | |
Founding Date | Founding Date 1991 | Founding Date 1990 | Founding Date 2011 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Lund, SE HQ Sydney, AU Mannheim, DE Duxford, GB | Locations Rehovot, IL HQ Beit Kama, IL | Locations San Diego, US HQ Dublin, IE |
Employees | Employees 265 | Employees 420 | Employees 46293% increase |
Valuation ($) | Valuation ($) 3.4 b | Valuation ($) 317 m | Valuation ($) 1.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) kr2.3b (FY, 2025) | Revenue (est.) $180.5m (FY, 2025) | Revenue (est.) $490.7m (FY, 2025) |
Cost of goods | Cost of goods kr138.7m (FY, 2025) | Cost of goods $72.1m (FY, 2025) | Cost of goods $10.3m (FY, 2025) |
Gross profit | Gross profit kr2.1b (FY, 2025) | Gross profit $108.4m (FY, 2025) | Gross profit $480.4m (FY, 2025) |
Net income | Net income kr735.6m (FY, 2025) | Net income $20.2m (FY, 2025) | Net income ($25.5m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 90m | Total funding raised $ 25m |
For sources of this data, please see the company profile
View Company Profiles
Kamada Pharmaceuticals
HQ
Rehovot, IL
Employees
420
Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.
View companyTravere Therapeutics
HQ
San Diego, US
Employees
462
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View company